IMPACT OF THERAPY INTENSIFICATION BY AN INTEGRASE INHIBITOR +/- CCR5 INHIBITOR ON THE LYMPHOID RESERVOIR FOR HIV-1 IN CHRONICALLY INFECTED PATIENTS.
Phase of Trial: Phase III
Latest Information Update: 17 May 2017
At a glance
- Drugs Raltegravir (Primary) ; HIV protease inhibitors; Maraviroc; Ritonavir; RNA-directed DNA polymerase inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms IntensVIH
- 07 Jun 2017 Biomarkers information updated
- 16 Apr 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 24 Jan 2013 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.